Switch to:
Progenics Pharmaceuticals Inc (NAS:PGNX)
EV/Revenue
34.29 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, Progenics Pharmaceuticals Inc's enterprise value is $241.59 Mil. Progenics Pharmaceuticals Inc's revenue for the trailing twelve months (TTM) ended in Jun. 2014 was $7.13 Mil. Therefore, Progenics Pharmaceuticals Inc's EV/Revenue ratio for today is 34.29.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Progenics Pharmaceuticals Inc's stock price is $4.70. Progenics Pharmaceuticals Inc's revenue per share for the trailing twelve months (TTM) ended in Jun. 2014 was $0.11. Therefore, Progenics Pharmaceuticals Inc's P/S Ratio for today is 42.00.


Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Progenics Pharmaceuticals Inc's EV/Revenue for today is calculated as:

EV/Revenue=Enterprise Value (Today)/Revenue (TTM)
=241.586/7.127
=33.90

Progenics Pharmaceuticals Inc's current Enterprise Value is $241.59 Mil.
Progenics Pharmaceuticals Inc's Revenue for the trailing twelve months (TTM) ended in Jun. 2014 was 0.867 (Sep. 2013 ) + 2.968 (Dec. 2013 ) + 1.815 (Mar. 2014 ) + 1.477 (Jun. 2014 ) = $7.13 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Progenics Pharmaceuticals Inc's P/S Ratio for today is calculated as:

P/S Ratio=Share Price (Today)/Revenue Per Share (TTM)
=4.70/0.11
=42.73

Progenics Pharmaceuticals Inc's share price for today is $4.70.
Progenics Pharmaceuticals Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Jun. 2014 was 0.01 (Sep. 2013 ) + 0.05 (Dec. 2013 ) + 0.03 (Mar. 2014 ) + 0.02 (Jun. 2014 ) = $0.11.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Revenue, P/S Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Progenics Pharmaceuticals Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2rev 27.7247.077.805.372.931.0116.722.585.6932.86

Progenics Pharmaceuticals Inc Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
ev2rev 3.3023.547.675.6915.6113.2816.6732.8624.9430.09
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK